Trade Summary

3 days ago, Patel Sanjiv, serving as President and CEO at Relay Therapeutics, Inc. (RLAY), sold 48,199 shares at $19.58 per share, for a total transaction value of $943,736.42. Following this transaction, Patel Sanjiv now holds 615,898 shares of RLAY.

This sale represents a 7.26% decrease in Patel Sanjiv's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 7, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 8, 2026 at 5:08 PM ET, 1 day after the trade was made.

Relay Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.